Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Filings indexed 1,332 across all filing types
Latest filing 2015-11-11 Annual Report
Country DK Denmark
Listing CO AMBU

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Annual Report 2015
Annual Report
2015-11-11 English
Regulatory Filings 2015
Regulatory Filings Classification · 99% confidence The document text is very short (153 characters) and written in Danish. It announces the publication of a result from a collaboration between Ambu and Coloplast regarding a urology product development, presented at an endourology congress in London. This is not a standard regulatory filing (like 10-K, IR, ER) nor does it fit clearly into management changes, financing, or dividends. Given its nature as a specific, non-standard announcement of a joint development result presented at an event, and lacking the structure of a formal report, it best fits the general 'Regulatory Filings' fallback category (RNS) as a miscellaneous corporate announcement that doesn't match the highly specific definitions provided.
2015-10-02 Danish
M&A Activity 2015
M&A Activity Classification · 99% confidence The document is a press release written in Danish announcing a new partnership between Ambu and Coloplast regarding a visualization product for the urology market. It discusses the strategic importance and future commercial potential of the agreement. Crucially, it mentions that the significance of the partnership will be further detailed on November 11th in connection with the presentation of Ambu's annual report for 2014/15. Since this document is an announcement of a business development/partnership, and not a formal regulatory filing like a 10-K, ER, or IR, it fits best into the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially a general announcement if a more specific category existed. Given the provided definitions, RNS (Regulatory Filings) is the most appropriate fallback for a general corporate press release that doesn't fit the other specific categories (like DIV, CAP, MANG, etc.). The document length (2464 chars) is short, but it is the primary content, not an announcement *about* another report, although it references the upcoming annual report presentation.
2015-10-02 English
M&A Activity 2015
M&A Activity Classification · 99% confidence The document text describes a partnership agreement between Ambu Inc. and Tri-anim Health Services Inc. for product distribution in North America, effective October 1, 2015. This content relates to a significant business arrangement or strategic alliance, which does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.) or corporate governance categories (MANG, DIRS, DIV). Since it is a specific business announcement that doesn't match the defined categories like M&A (TAR), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory announcements.
2015-09-24 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 86% confidence The document text describes a new distribution partnership between Ambu Inc. and Tri-anim Health Services Inc., effective October 1, 2015. This is an announcement regarding a significant business agreement or strategic alliance, which does not fit neatly into the defined categories like Earnings Release (ER), Annual Report (10-K), or Capital/Financing (CAP). Since it relates to a business transaction that is not explicitly a merger/takeover (TAR), the most appropriate fallback category is Regulatory Filings (RNS) for general regulatory announcements that don't fit elsewhere.
2015-09-24 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 95% confidence The document text is a 'Financial Diary' outlining key dates for future corporate events, specifically mentioning deadlines for AGM agenda items, the release of the Annual Report (Earnings Release), and the date of the Ordinary Annual General Meeting. It also lists dates for quarterly reports (Q1, Q2, Q3) and the fiscal year end. This content is a schedule of corporate events and reporting deadlines, not the actual report itself. Since it announces the timing of reports and meetings, it fits best under Report Publication Announcement (RPA) or potentially Regulatory Filings (RNS). Given that it specifically schedules the release of the Annual Report and Quarterly Reports, RPA is the most precise fit, as it announces the publication schedule.
2015-09-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.